GE Healthcare to Acquire Clarient Inc
GE Healthcare, a unit of General Electric Company, and Clarient Inc announced have entered into a definitive agreement for GE Healthcare to acquire Clarient.
Read MoreSearch Results for: lung cancer
Study Details Gene Signature Used by LungExpress Dx
Med BioGene Inc announced the publication of a study detailing the development and validation of the 15-gene signature used by LungExpress Dx entitled “Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer”.
Read MoreRadient Pharmaceuticals Announces Its 2010 Onko-Sure Reference Guide
Radient Pharmaceuticals Corp (RPC) announced broad availability of its 2010 Onko-Sure Reference Guide for the Company’s USFDA-approved Onko-Sure in vitro diagnostic (IVD) cancer test kit.
Read MoreResearch and Markets Report Delves into Lung Cancer Test Development
Research and Markets has announced the addition of the “The Top 20 Developers of Molecular Diagnostic Tests for Lung Cancer” report to their offering.
Read More
Oncology Testing: Becoming More Effective, Specific, and Predictive
Advances in genomics and biomarker identification facilitate more accurate diagnoses for cancer patients.
Read More